These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. An Exploration of the Inhibitory Mechanism of Rationally Screened Benzofuran-1,3,4-Oxadiazoles and-1,2,4-Triazoles as Inhibitors of NS5B RdRp Hepatitis C Virus through Pharmacoinformatic Approaches. Irfan A; Faisal S; Ahmad S; Saif MJ; Zahoor AF; Khan SG; Javid J; Al-Hussain SA; Muhammed MT; Zaki MEA Biomedicines; 2023 Nov; 11(11):. PubMed ID: 38002085 [TBL] [Abstract][Full Text] [Related]
5. In Silico Development of Novel Benzofuran-1,3,4-Oxadiazoles as Lead Inhibitors of Irfan A; Faisal S; Zahoor AF; Noreen R; Al-Hussain SA; Tuzun B; Javaid R; Elhenawy AA; Zaki MEA; Ahmad S; Abdellattif MH Pharmaceuticals (Basel); 2023 Jun; 16(6):. PubMed ID: 37375776 [TBL] [Abstract][Full Text] [Related]
6. A novel bis-triazole scaffold accessed via two tandem [3 + 2] cycloaddition events including an uncatalyzed, room temperature azide-alkyne click reaction. Malkova K; Bubyrev A; Krivovicheva V; Dar'in D; Bunev A; Krasavin M Beilstein J Org Chem; 2022; 18():1636-1641. PubMed ID: 36530536 [TBL] [Abstract][Full Text] [Related]
7. Structure-Activity Relationship of Benzofuran Derivatives with Potential Anticancer Activity. Farhat J; Alzyoud L; Alwahsh M; Al-Omari B Cancers (Basel); 2022 Apr; 14(9):. PubMed ID: 35565325 [TBL] [Abstract][Full Text] [Related]
8. Modular Entry to Functionalized Tetrahydrobenzo[ Liu X; Wang J; Dong G J Am Chem Soc; 2021 Jul; 143(26):9991-10004. PubMed ID: 34161077 [TBL] [Abstract][Full Text] [Related]
9. Last Decade of Unconventional Methodologies for the Synthesis of Substituted Benzofurans. Chiummiento L; D'Orsi R; Funicello M; Lupattelli P Molecules; 2020 May; 25(10):. PubMed ID: 32429435 [TBL] [Abstract][Full Text] [Related]
10. New pseudodimeric aurones as palm pocket inhibitors of Hepatitis C virus RNA-dependent RNA polymerase. Meguellati A; Ahmed-Belkacem A; Nurisso A; Yi W; Brillet R; Berqouch N; Chavoutier L; Fortuné A; Pawlotsky JM; Boumendjel A; Peuchmaur M Eur J Med Chem; 2016 Jun; 115():217-29. PubMed ID: 27017550 [TBL] [Abstract][Full Text] [Related]
11. Recent advances on the synthesis of hepatitis C virus NS5B RNA-dependent RNA-polymerase inhibitors. Zhao C; Wang Y; Ma S Eur J Med Chem; 2015 Sep; 102():188-214. PubMed ID: 26276434 [TBL] [Abstract][Full Text] [Related]
12. Nucleoside Inhibitors of Hepatitis C Virus NS5B Polymerase: A Systematic Review. Xie Y; Ogah CA; Jiang X; Li J; Shen J Curr Drug Targets; 2016; 17(13):1560-76. PubMed ID: 26648061 [TBL] [Abstract][Full Text] [Related]
13. Discovery of novel potent HCV NS5B polymerase non-nucleoside inhibitors bearing a fused benzofuran scaffold. Zhong M; Peng E; Huang N; Huang Q; Huq A; Lau M; Colonno R; Li L Bioorg Med Chem Lett; 2018 Mar; 28(5):963-968. PubMed ID: 29422387 [TBL] [Abstract][Full Text] [Related]
14. Design and evaluation of novel tetracyclic benzofurans as palm site allosteric inhibitors of HCV NS5B polymerase. Liu H; Dai X; He S; Brockunier L; Marcantonio K; Ludmerer SW; Li F; Feng KI; Nargund RP; Palani A Bioorg Med Chem Lett; 2019 Dec; 29(24):126104. PubMed ID: 30389294 [TBL] [Abstract][Full Text] [Related]
15. Multi-step parallel synthesis enabled optimization of benzofuran derivatives as pan-genotypic non-nucleoside inhibitors of HCV NS5B. Xiao D; Dai X; Liu H; He S; Shi ZC; Ludmerer SW; Li F; Nargund R; Palani A Bioorg Med Chem Lett; 2020 Apr; 30(7):127004. PubMed ID: 32061500 [TBL] [Abstract][Full Text] [Related]